Literature DB >> 25576212

Thyroid cancer in Egypt: histopathological criteria, correlation with survival and oestrogen receptor protein expression.

Rehab Allah Ahmed1, Engy M Aboelnaga.   

Abstract

Thyroid cancer represents approximately 1% of new cancer and oestrogen may play a role in the pathogenesis of thyroid neoplasm. We aimed to study the clinicopathological criteria and ER expression of thyroid cancer in Mansoura University (Egypt), and to correlate the survival to these clinicopathological data and ER expression. This retrospective study reviewed 644 patients with histologically proven thyroid carcinoma during the period from 2003 to 2011. 152 cases during the period between 2008 and 2011 were retrieved from the archive and examined by immunohistochemistry for oestrogen receptor-α (ER) expression. ER-α expression is significantly associated with the female sex, lymph node metastasis, TNM stage, extrathyroid extension, multifocality disease and recurrence and in the whole series (p < 0.5). The same was noticed in papillary carcinoma (PTC) except the gender of the patient. Tumour type, extrathyroid extension and ER expression were the independent prognostic factors of DFS, while in PTC, only ER expression was the independent one. The histological type was the only independent prognostic factor for OAS in the series were studied for ER expression, while extrathyroid extension was the only one that affected OAS of PTC. There was significant positive correlation with lymph node metastasis and ER expression in whole patient and PTC cases. No difference in survival between the low and high ranges of positive oestrogen expression. The prognosis of thyroid carcinoma in Egypt is similar to that occurs worldwide. ER-α expression was a significant prognostic marker for DFS in thyroid cancer and can be used as a predictive factor of lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25576212     DOI: 10.1007/s12253-014-9892-5

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  24 in total

1.  Reproductive factors and risk of papillary thyroid cancer in women.

Authors:  M A Rossing; L F Voigt; K G Wicklund; J R Daling
Journal:  Am J Epidemiol       Date:  2000-04-15       Impact factor: 4.897

2.  Thyroid cancer pooled analysis from 14 case-control studies: what have we learned?

Authors:  Susan Preston-Martin; Silvia Franceschi; Elaine Ron; Eva Negri
Journal:  Cancer Causes Control       Date:  2003-10       Impact factor: 2.506

3.  Anti-proliferative effect of toremifene and tamoxifen on estrogen receptor-lacking anaplastic thyroid carcinoma cell lines.

Authors:  T Kishino; M Watanabe; M Kimura; I Sugawara
Journal:  Biol Pharm Bull       Date:  1997-12       Impact factor: 2.233

4.  Establishment of an intraoperative staging system (iStage) by improving UICC TNM classification system for papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Kiyoshi Ichihara; Hiroo Masuoka; Mitsuhiro Fukushima; Hiroyuki Inoue; Minoru Kihara; Chisato Tomoda; Takuya Higashiyama; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya; Akira Miyauchi
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

5.  Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups.

Authors:  Guo-Pei Yu; James Chun-Lun Li; Daniel Branovan; Steven McCormick; Stimson P Schantz
Journal:  Thyroid       Date:  2010-05       Impact factor: 6.568

6.  Prognostic factors in well-differentiated thyroid carcinoma.

Authors:  Sharon L Cushing; Carsten E Palme; Nathalie Audet; Spiro Eski; Paul G Walfish; Jeremy L Freeman
Journal:  Laryngoscope       Date:  2004-12       Impact factor: 3.325

Review 7.  Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer.

Authors:  George G Chen; Alexander C Vlantis; Qiang Zeng; C Andrew van Hasselt
Journal:  Curr Cancer Drug Targets       Date:  2008-08       Impact factor: 3.428

8.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].

Authors:  S A Hundahl; I D Fleming; A M Fremgen; H R Menck
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

9.  International patterns and trends in thyroid cancer incidence, 1973-2002.

Authors:  Briseis A Kilfoy; Tongzhang Zheng; Theodore R Holford; Xuesong Han; Mary H Ward; Andreas Sjodin; Yaqun Zhang; Yana Bai; Cairong Zhu; Grace L Guo; Nathaniel Rothman; Yawei Zhang
Journal:  Cancer Causes Control       Date:  2008-11-19       Impact factor: 2.506

10.  Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.

Authors:  C Passler; C Scheuba; G Prager; K Kaczirek; K Kaserer; G Zettinig; B Niederle
Journal:  Endocr Relat Cancer       Date:  2004-03       Impact factor: 5.678

View more
  6 in total

1.  Estrogen and thyroid cancer is a stem affair: A preliminary study.

Authors:  Mariangela Zane; Carmelo Parello; Gianmaria Pennelli; Danyelle M Townsend; Stefano Merigliano; Marco Boscaro; Antonio Toniato; Giovannella Baggio; Maria Rosa Pelizzo; Domenico Rubello; Isabella Merante Boschin
Journal:  Biomed Pharmacother       Date:  2016-11-26       Impact factor: 6.529

2.  Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.

Authors:  Wenwu Dong; Jing Li; Hao Zhang; Yanhong Huang; Liang He; Zhihong Wang; Zhongyan Shan; Weiping Teng
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  ZNF703 is Overexpressed in Papillary Thyroid Carcinoma Tissues and Mediates K1 Cell Proliferation.

Authors:  Xiaolin Yang; Geling Liu; Luyang Zang; Ding Li; Fang Yu; Xiuxiu Xiang; Weijuan Li
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

Review 4.  The Emerging Role of Estrogens in Thyroid Redox Homeostasis and Carcinogenesis.

Authors:  Caroline C Faria; Milena S Peixoto; Denise P Carvalho; Rodrigo S Fortunato
Journal:  Oxid Med Cell Longev       Date:  2019-01-09       Impact factor: 6.543

5.  Signaling Complexity Measured by Shannon Entropy and Its Application in Personalized Medicine.

Authors:  Alessandra J Conforte; Jack Adam Tuszynski; Fabricio Alves Barbosa da Silva; Nicolas Carels
Journal:  Front Genet       Date:  2019-10-21       Impact factor: 4.599

6.  Decline in radioiodine use but not total thyroidectomy in thyroid cancer patients treated in the United Arab Emirates - A retrospective study.

Authors:  Malik Azhar; Faisal Aziz; Salama Almuhairi; Mohammad Alfelasi; Ali Elhouni; Rizwan Syed; Humaid O Al-Shamsi; Khaled M Aldahmani
Journal:  Ann Med Surg (Lond)       Date:  2021-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.